NewAge, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 10 rows, 10 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2021-03-10: Reporting owner Gould Gregory A; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-01-24: Reporting owner VANDERVEEN DAVID; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-01-24: Reporting owner VANDERVEEN DAVID; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2019-12-10: Reporting owner Gould Gregory A; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2021-03-10 | Gould Gregory A Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +125,000 125,000 owned after | $2.79 exercise price | 2021-03-12 | |
| 2020-01-24 | VANDERVEEN DAVID Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +125,000 125,000 owned after | $1.77 exercise price | 2020-01-28 | |
| 2020-01-24 | VANDERVEEN DAVID Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $1.77 exercise price | 2020-01-28 | |
| 2019-12-10 | Gould Gregory A Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $1.83 exercise price | 2019-12-12 | |
| 2019-12-10 | Garlikov Julie Officer (Chief Marketing Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $1.83 exercise price | 2019-12-12 | |
| 2019-12-10 | Willis Brent D Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +162,500 162,500 owned after | $1.83 exercise price | 2019-12-12 | |
| 2019-08-30 | Willis Brent D Director, Officer (Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +213,815 213,815 owned after | $3.04 exercise price | 2019-09-03 | |
| 2019-07-01 | Gould Gregory A Officer (CFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $4.75 exercise price | 2019-07-03 | |
| 2019-02-06 holding as of filing | RIFE RICHARD C Officer (See Remarks) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $4.63 exercise price | 2019-02-06 | ||
| 2019-02-06 holding as of filing | Smith Randall Ned Officer (President of Morinda Holdings) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $4.63 exercise price | 2019-02-06 |